In vitro activities of linezolid, meropenem, and quinupristin-dalfopristin against group C and G streptococci, including vancomycin-tolerant isolates

被引：8
|
作者：
Zaoutis, T
Moore, LS
Furness, K
Klein, JD
机构：
[1] Alfred I duPont Hosp Children, Div Pediat Infect Dis, Wilmington, DE 19899 USA
[2] Christiana Hosp, Christiana Care Hlth Syst, Infect Dis Lab, Newark, DE USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2001年 / 45卷 / 07期
关键词：
D O I：
10.1128/AAC.45.7.1952-1954.2001
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The in vitro activities of meropenem, linezolid, quinupristin dalfopristin, vancomycin, and penicillin against 130 clinical isolates of group C and G streptococci, including vancomycin-tolerant isolates, were evaluated. Meropenem, linezolid, quinupristin-dalfopristin, vancomycin, and penicillin MICs at which 90% of the isolates were inhibited were 0.06, 2.0, 0.25, 0.5, and less than or equal to0.016 mug/ml, respectively. Meropenem, linezolid, quinupristin-dalfopristin, and penicillin were active against group C and G streptococci, including vancomycin-resistant strains.
引用
收藏
页码：1952 / 1954
页数：3
相关论文
共 44 条
  • [1] In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains
    Rybak, MJ
    Hershberger, E
    Moldovan, T
    Grucz, RG
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (04) : 1062 - 1066
  • [2] Investigation of Linezolid, Daptomycin, Quinupristin-Dalfopristin and Tigecycline Susceptibilities against Vancomycin Resistant Enterococcus Isolates
    Yasemin, C. A. G.
    Serap, Gencer
    Oznur, A. K.
    Yakup, C. A. G.
    Serdar, Ozer
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2013, 7 (02): : 1367 - 1371
  • [3] Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci
    Betriu, C
    Redondo, M
    Palau, ML
    Sánchez, A
    Gómez, M
    Culebras, E
    Boloix, A
    Picazo, JJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) : 1838 - 1841
  • [4] In vitro activities of daptomycin, vancomycin, quinupristin-dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates
    Goldstein, EJC
    Citron, DM
    Merriam, CV
    Warren, YA
    Tyrrell, KL
    Fernandez, HT
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (01) : 337 - 341
  • [5] In vitro activities of daptomycin, linezolid, and quinupristin-dalfopristin against a challenge panel of staphylococci and enterococci, including vancomycin-intermediate Staphylococcus aureus and vancomycin-resistant Enterococcus faecium
    Jevitt, LA
    Smith, AJ
    Williams, PP
    Raney, PM
    McGowan, JE
    Tenover, FC
    MICROBIAL DRUG RESISTANCE, 2003, 9 (04) : 389 - 393
  • [6] Comparative in-vitro activities of quinupristin-dalfopristin against Gram-positive bloodstream isolates
    Schouten, MA
    HoogkampKorstanje, JAA
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (02) : 213 - 219
  • [7] Bactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations
    Cha, R
    Brown, WJ
    Rybak, MJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (12) : 3960 - 3963
  • [8] In vitro activities of telithromycin, linezolid, and quinupristin-dalfopristin against Streptococcus pneumoniae with macrolide resistance due to ribosomal mutations
    Farrell, DJ
    Morrissey, I
    Bakker, S
    Buckridge, S
    Felmingham, D
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (08) : 3169 - 3171
  • [9] In vitro activities of quinupristin-dalfopristin and the streptogramin RPR 106972 against Mycoplasma pneumoniae
    Izumikawa, K
    Hirakata, Y
    Yamaguchi, T
    Yoshida, R
    Tanaka, H
    Takemura, H
    Maesaki, S
    Tomono, K
    Kaku, M
    Izumikawa, KI
    Kamihira, S
    Kohno, S
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (03) : 698 - 699
  • [10] In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci
    El-Azizi M.
    Rao S.
    Kanchanapoom T.
    Khardori N.
    Annals of Clinical Microbiology and Antimicrobials, 4 (1)
12345